20709368|t|The fibrinogen gamma 10034C>T polymorphism is not associated with Peripheral Arterial Disease.
20709368|a|Conversion of fibrinogen to fibrin plays an essential role in hemostasis and results in stabilization of the fibrin clot. Fibrinogen consists of three pairs of non-identical polypeptide chains, encoded by different genes (fibrinogen alpha [FGA], fibrinogen beta [FGB] and fibrinogen gamma [FGG]). A functional single nucleotide polymorphism (SNP) in the 3' untranslated region of the FGG gene (FGG 10034C>T, rs2066865) has been associated with deep venous thrombosis and myocardial infarction. Aim of the present study was to analyze the role of this polymorphism in peripheral arterial disease (PAD). The study was designed as case-control study including 891 patients with documented PAD and 777 control subjects. FGG genotypes were determined by exonuclease (TaqMan) assays. FGG genotype frequencies were not significantly different between PAD patients (CC: 57.3%, CT: 36.7%, TT: 5.8%) and control subjects (CC: 60.9%, CT: 33.5%, TT 5.6%; p=0.35). In a multivariate logistic regression analysis including age, sex, smoking, diabetes, arterial hypertension and hypercholesterolemia, the FGG 10034 T variant was not significantly associated with the presence of PAD (Odds ratio 1.07, 95% confidence interval 0.84 - 1.37; p = 0.60). The FGG 10034C>T polymorphism was furthermore not associated with age at onset of PAD. We conclude that the thrombophilic FGG 10034 T gene variant does not contribute to the genetic susceptibility to PAD.
20709368	4	20	fibrinogen gamma	GeneOrGeneProduct	2266
20709368	21	29	10034C>T	SequenceVariant	rs2066865
20709368	66	93	Peripheral Arterial Disease	DiseaseOrPhenotypicFeature	D058729
20709368	109	119	fibrinogen	GeneOrGeneProduct	2243,2244,2266
20709368	123	129	fibrin	GeneOrGeneProduct	2243,2244,2266
20709368	204	210	fibrin	GeneOrGeneProduct	2243,2244,2266
20709368	217	227	Fibrinogen	GeneOrGeneProduct	2243,2244,2266
20709368	317	333	fibrinogen alpha	GeneOrGeneProduct	2243
20709368	335	338	FGA	GeneOrGeneProduct	2243
20709368	341	356	fibrinogen beta	GeneOrGeneProduct	2244
20709368	358	361	FGB	GeneOrGeneProduct	2244
20709368	367	383	fibrinogen gamma	GeneOrGeneProduct	2266
20709368	385	388	FGG	GeneOrGeneProduct	2266
20709368	479	482	FGG	GeneOrGeneProduct	2266
20709368	489	492	FGG	GeneOrGeneProduct	2266
20709368	493	501	10034C>T	SequenceVariant	rs2066865
20709368	503	512	rs2066865	SequenceVariant	rs2066865
20709368	539	561	deep venous thrombosis	DiseaseOrPhenotypicFeature	D020246
20709368	566	587	myocardial infarction	DiseaseOrPhenotypicFeature	D009203
20709368	662	689	peripheral arterial disease	DiseaseOrPhenotypicFeature	D058729
20709368	691	694	PAD	DiseaseOrPhenotypicFeature	D058729
20709368	756	764	patients	OrganismTaxon	9606
20709368	781	784	PAD	DiseaseOrPhenotypicFeature	D058729
20709368	811	814	FGG	GeneOrGeneProduct	2266
20709368	873	876	FGG	GeneOrGeneProduct	2266
20709368	939	942	PAD	DiseaseOrPhenotypicFeature	D058729
20709368	943	951	patients	OrganismTaxon	9606
20709368	1123	1131	diabetes	DiseaseOrPhenotypicFeature	D003920
20709368	1142	1154	hypertension	DiseaseOrPhenotypicFeature	D006973
20709368	1159	1179	hypercholesterolemia	DiseaseOrPhenotypicFeature	D006937
20709368	1185	1188	FGG	GeneOrGeneProduct	2266
20709368	1189	1196	10034 T	SequenceVariant	rs2066865
20709368	1259	1262	PAD	DiseaseOrPhenotypicFeature	D058729
20709368	1333	1336	FGG	GeneOrGeneProduct	2266
20709368	1337	1345	10034C>T	SequenceVariant	rs2066865
20709368	1411	1414	PAD	DiseaseOrPhenotypicFeature	D058729
20709368	1451	1454	FGG	GeneOrGeneProduct	2266
20709368	1455	1462	10034 T	SequenceVariant	rs2066865
20709368	1529	1532	PAD	DiseaseOrPhenotypicFeature	D058729
20709368	Association	rs2066865	D009203	No
20709368	Association	rs2066865	D020246	No
20709368	Association	2266	D009203	No
20709368	Association	2266	D020246	No